Provention Bio
Latest round
- Series A
Last raised
- Apr 2017
Total raised
- $28M
Investors
- 2
About Provention Bio
Founded in 2016 and based in New Jersey, US, Provention Bio, Inc. operates as a biopharmaceutical company that develops therapeutics to prevent autoimmune and inflammatory diseases., a portfolio company of Advanz Pharma Services (UK) Limited and Nordic Capital, agreed to acquire Provention Bio, Inc.9 billion in equity, at USD 25 per share in cash. Ashleigh Palmer, co-founder and CEO of Provention Bio, is also the Founder and President of Creative BioVentures™ Corp. (CBV), and Heidy Abreu King-Jones, the chief legal officer, was the SVP and GC of Axcella Health. The pipelines provided by the company include Intercepting Autoimmune Disease, Autoimmune Candidates, and Expanded Patient Access. The company has created a pipeline of investigational candidates that target upstream autoimmune pathways and even viral triggers with the goal of intercepting and preventing life-threatening and debilitating immune-mediated diseases, including type 1 diabetes (T1D), celiac disease, and lupus.
Who invested in Provention Bio
2 investors across 1 round
See all investors in Provention Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 25, 2017
Amount
$28M
Investors
Questions about Provention Bio
Who invested in Provention Bio?
Provention Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Provention Bio raised?
Provention Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Provention Bio last raise money?
Provention Bio's most recent round on record is a Series A, in Apr 2017.
What does Provention Bio do?
Founded in 2016 and based in New Jersey, US, Provention Bio, Inc.
Where is Provention Bio headquartered?
Provention Bio is headquartered in Red Bank, US.
Which VCs invest in companies like Provention Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Provention Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Provention Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.